Back
Structure Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
GPCR
Structure Therapeutics, Inc.
Last Price:
$63.14
Seasonality Move:
11.23%
7 Day Trial
ALL ACCESS PASS
$
7
Structure Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Structure Therapeutics, Inc. has on average historically risen by 81% based on the past 3 years of stock performance.
-
Structure Therapeutics, Inc. has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Structure Therapeutics, Inc. Stock Undervalued?The current Structure Therapeutics, Inc. [GPCR] share price is $62.90. The Score for GPCR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
GPCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Structure Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Structure Therapeutics, Inc. has on average historically risen by 81% based on the past 3 years of stock performance.
Structure Therapeutics, Inc. Stock Rating
Sell
43
Structure Therapeutics, Inc. (GPCR)
is a Sell
Is Structure Therapeutics, Inc. overpriced?
-
Structure Therapeutics, Inc. has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Structure Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
structuretx.com
52-Week Data
52-Week High:
94.90
52-Week Low:
13.22
Prediction Charts
Market Cap:
4.4B
Price in USD:
62.90
Volume:
518.5K
Beta:
-1.88
Technical Analysis
SMA50:
74.44
SMA100:
55.62
SMA200:
38.32
52-Wk Change:
164.84%
Stock Predictions
-
Is Structure Therapeutics, Inc. stock public?Yes, Structure Therapeutics, Inc. is a publicly traded company.
-
What is the Structure Therapeutics, Inc. stock quote today?The Structure Therapeutics, Inc. stock price is 62.90 USD today.
-
How to buy Structure Therapeutics, Inc. stock online?You can buy Structure Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-10 | 76.82 | 78.55 | 81.15 | 76.82 |
| Feb-11 | 78.65 | 75.98 | 79.10 | 74.34 |
| Feb-12 | 75.82 | 72.04 | 77.35 | 71.81 |
| Feb-13 | 72.10 | 70.07 | 73.33 | 69.95 |
| Feb-17 | 69.61 | 71.41 | 72.31 | 68.65 |
| Feb-18 | 71.23 | 68.36 | 71.70 | 68.20 |
| Feb-19 | 68.23 | 67.47 | 68.23 | 64.96 |
| Feb-20 | 67.11 | 66.55 | 68.14 | 65.58 |
| Feb-23 | 67.78 | 67.12 | 68.26 | 66.16 |
| Feb-24 | 67.12 | 68.91 | 68.96 | 64.84 |
| Feb-25 | 69.00 | 66.53 | 69.00 | 66.40 |
| Feb-26 | 66.24 | 64.75 | 66.25 | 63.07 |
| Feb-27 | 64.13 | 62.98 | 65.05 | 62.17 |
| Mar-2 | 61.88 | 62.90 | 64.37 | 61.51 |
Structure Therapeutics, Inc. Earnings
Structure Therapeutics, Inc. Earnings Report: Per Share Structure Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Structure Therapeutics, Inc. Forecast Revenue Growth
Structure Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Structure Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.21 per share, and a decrease next year of $0.30 per share.
* Structure Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.